ZnO-Based Nanoparticles for Targeted Cancer Chemotherapy and the Role of Tumor Microenvironment: A Systematic Review
International Journal of Molecular Sciences · 29.08.2025 · 26 (17) · 8417
DOI: 10.3390/ijms26178417 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.08.2025. Verfasst von Vasilis-Spyridon Tseriotis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Agios Pavlos General Hospital of Thessaloniki, Leoforos Ethnikis Antistaseos 161, Kalamaria, 55134 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Zinc Oxide, Tumor Microenvironment, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Cancer, a leading global cause of death responsible for nearly 10 million deaths annually, demands innovative therapeutic strategies. Intrinsic cytotoxicity and biocompatibility of zinc oxide nanoparticles (ZnO-NPs) have rendered them promising nanoplatforms in oncology. We herein systematically review their applications for targeted cancer chemotherapy, with a focus on physicochemical properties, drug delivery mechanisms, and interactions with the tumor microenvironment (TME). We searched PubMed, SCOPUS, and Web of Science from inception through December 2024 for peer-reviewed preclinical studies on cancer models. Results were qualitatively synthesized. Quality was assessed with the SYRCLE risk of bias tool. Among 20 eligible studies, ZnO-NPs were frequently functionalized with ligands to enhance tumor targeting and minimize systemic toxicity. Chemotherapeutic agents (doxorubicin, 5-fluorouracil, docetaxel, cisplatin, gemcitabine, and tirapazamine) were loaded into ZnO-based carriers, with improved anticancer efficacy compared to free drug formulations, particularly in multidrug-resistant cell lines and in vivo murine xenografts. The mildly acidic TME was exploited for pH-responsive drug release, premature leakage reduction, and improvement of intratumoral accumulation. Enhanced therapeutic outcomes were attributed to reactive oxygen species generation, zinc ion-mediated cytotoxicity, mitochondrial dysfunction, and efflux pump inhibition. Deep tumor penetration, apoptosis induction, and tumor growth suppression were also reported, with minimal toxicity to healthy tissues. ZnO-NPs might constitute a versatile and promising strategy for targeted cancer chemotherapy, offering synergistic anticancer effects and improved safety profiles. Future studies emphasizing long-term toxicity, immune responses, and scalable production could lead to clinical translation of ZnO-based nanomedicine in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Agios Pavlos General Hospital of Thessaloniki, Leoforos Ethnikis Antistaseos 161, Kalamaria, 55134 Thessaloniki, Greece.
- Laboratory of Clinical Pharmacology, Aristotle University Campus, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Respiratory Department, Cavan & Monaghan Hospital, HSE/RCSI, H12Y7W1 Cavan, Ireland.
- RCSI University of Medicine & Health Sciences, 123 St. Stephen's Green, Dublin D02 YN77, Ireland.
- Research Team "Histologistas", Interinstitutional Postgraduate Program "Health and Environmental Factors", Department of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Gr…
- Laboratory of Histology-Embryology, Department of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Vasilis-Spyridon Tseriotis, Sofia Karachrysafi, Theodora Papamitsou, Georgios Petrakis, Dimitrios Kouvelas, Paraskevas Mavropoulos, Konstantinos Lallas, Aleksandar Sič, Vasileios Fouskas, Konstantinos Stergiou
Zitieren
APA
Tseriotis, V. S., Ampazis, D., Karachrysafi, S., Papamitsou, T., Petrakis, G., Kouvelas, D., Mavropoulos, P., Lallas, K., Sič, A., Fouskas, V., Stergiou, K., Pavlidis, P., & Arnaoutoglou, M. (2025). ZnO-Based Nanoparticles for Targeted Cancer Chemotherapy and the Role of Tumor Microenvironment: A Systematic Review. International Journal of Molecular Sciences, 26(17), 8417. https://doi.org/10.3390/ijms26178417
Vancouver
Tseriotis VS, Ampazis D, Karachrysafi S, Papamitsou T, Petrakis G, Kouvelas D, et al. ZnO-Based Nanoparticles for Targeted Cancer Chemotherapy and the Role of Tumor Microenvironment: A Systematic Review. International Journal of Molecular Sciences. 2025;26(17):8417. doi:10.3390/ijms26178417
BibTeX
@article{Tseriotis2025,
author = {Tseriotis, Vasilis-Spyridon and Ampazis, Dimitrios and Karachrysafi, Sofia and Papamitsou, Theodora and Petrakis, Georgios and Kouvelas, Dimitrios and Mavropoulos, Paraskevas and Lallas, Konstantinos and Sič, Aleksandar and Fouskas, Vasileios and Stergiou, Konstantinos and Pavlidis, Pavlos and Arnaoutoglou, Marianthi},
title = {ZnO-Based Nanoparticles for Targeted Cancer Chemotherapy and the Role of Tumor Microenvironment: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8417},
doi = {10.3390/ijms26178417}
}
EUVIMED